Showing results (2201-2210 of 2,955) with videos related to
Sort By:
Pageof 296
Cancer Investigation|July 2, 2010
Patients' attitudes to informed consent for genomic research with donated samplesJ Ignacio Valle-Mansilla, Miguel Ruiz-Canela, Daniel P SulmasyCancer Investigation|July 2, 2010
Impact of clinical and non-clinical factors on the choice of HER2 test for breast cancerMahima Ashok, Paul Griffin, Michael HalpernCancer Investigation|July 20, 2010
Inhibition of human breast cancer cell invasion by siRNA against urokinase-type plasminogen activatorHong-Yan Huang, Ze-Fei Jiang, Qing-Xia Li, et al.Cancer Investigation|May 21, 2010
Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancerNasrollah Erfani, Mahbobeh Razmkhah, Abbas GhaderiCancer Investigation|September 30, 2010
Prognostic value of E-cadherin expression and CDH1 promoter methylation in patients with endometrial carcinomaTie-Zhong Yi, Jing Guo, Lili Zhou, et al.Cancer Investigation|September 30, 2010
Epigenetic alteration of the Wnt inhibitory factor-1 promoter is common and occurs in advanced stage of Tunisian nasopharyngeal carcinomaAli Fendri, Abdelmajid Khabir, Boutheina Hadri-Guiga, et al.Cancer Investigation|October 1, 2010
Anticancer properties of zoledronic acidJonathan Green, Allan LiptonCancer Investigation|August 10, 2010
Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell lineXiangfeng Song, Zhongwei Tian, Shuxing Wang, et al.Cancer Investigation|August 10, 2010
Localization and altered expression of nucleophosmin in the nuclear matrix during the differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBAQi-Fu Li, Jian Tang, Qing-Rong Liu, et al.Cancer Investigation|August 10, 2010
Suppression of migration and invasion of PC3 prostate cancer cell line via activating E-cadherin expression by small activating RNAQiqi Mao, Xiangyi Zheng, Kai Yang, et al.Pageof 296